The Journal of Experimental Medicine
ReproCELL
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 February 2003 doi:10.1084/jem.20021713
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 334K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.-H.
Right arrow Articles by Vidal, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.-H.
Right arrow Articles by Vidal, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/2/515 $5.00
The Journal of Experimental Medicine, Volume 197, Number 4, 515-526

Transgenic Expression of the Activating Natural Killer Receptor Ly49H Confers Resistance to Cytomegalovirus in Genetically Susceptible Mice

Seung-Hwan Lee1, Ahmed Zafer2, Yves de Repentigny2, Rashmi Kothary2, Michel L. Tremblay3, Philippe Gros3, Pascale Duplay4, John R. Webb1 and Silvia M. Vidal1

1 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
2 Centre for Molecular Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6, Canada
3 Department of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada
4 Institut National de la Recherche Scientifique-Institut Armand-Frappier, Universite du Quebec, Laval, Quebec H7V 1B7, Canada

Address correspondence to Silvia M. Vidal, Faculty of Medicine, University of Ottawa, Room 4207, 451 Smyth Rd., Ottawa, Ontario K1H 8M5, Canada. Phone: 613-562-5800 (8592); Fax: 613-562-5452; E-mail: svidal{at}uottawa.ca

Natural resistance to infection with mouse cytomegalovirus (MCMV) is controlled by a dominant locus, Cmv1. Cmv1 is linked to the Ly49 family of natural killer receptors on distal chromosome 6. While some studies localized Cmv1 as distal to the Ly49 gene cluster, genetic and functional analysis identified Ly49h as a pivotal factor in resistance to MCMV. The role of these two independent genomic domains in MCMV resistance was evaluated by functional complementation using transgenesis of bacterial artificial chromosomes (BAC) in genetically susceptible mice. Phenotypic and genetic characterization of the transgenic animals traced the resistance gene to a single region spanning the Ly49h gene. The appearance of the Ly49H protein in NK cells of transgenic mice coincided with the emergence of MCMV resistance, and there was a threshold Ly49H protein level associated with full recovery. Finally, transgenic expression of Ly49H in the context of either of the two independent susceptibility alleles, Cmv1sBALB or Cmv1sFVB, conferred resistance to MCMV infection. These results demonstrate that Ly49h is necessary and sufficient to confer MCMV resistance, and formally demonstrate allelism between Cmv1 and Ly49h. This panel of transgenic animals provides a unique resource to study possible pleiotropic effect of Cmv1.

Key Words: genetic complementation test • natural immunity • animal model • immunogenetics • natural killer cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS